These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10914325)

  • 41. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K; Sistla R; Shastri NR
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A review on liquid-filled hard gelatin capsules].
    Ma JH; Yang M; Zeng M; Chen XM; Lan J
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):602-5. PubMed ID: 18536390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stability study of amiodarone hydrochloride in capsules for paediatric patients using a high-performance liquid chromatography method.
    Rughoo L; Vigneron J; Zenier H; May I; Demoré B
    Ann Pharm Fr; 2012 Mar; 70(2):88-93. PubMed ID: 22500960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reactivity of enprostil stereoisomers in soft elastic gelatin capsules.
    Kenley RA; Fleitman JS; Partridge IW
    J Pharm Sci; 1986 Sep; 75(9):842-6. PubMed ID: 3097299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique.
    Li DX; Oh YK; Lim SJ; Kim JO; Yang HJ; Sung JH; Yong CS; Choi HG
    Int J Pharm; 2008 May; 355(1-2):277-84. PubMed ID: 18243606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and Characterisation of Modified Release Hard Gelatin Capsules, Based on In Situ Lipid Matrix Formation.
    Vasvári G; Csontos B; Sovány T; Regdon G; Bényei A; Váradi J; Bácskay I; Ujhelyi Z; Fehér P; Sinka D; Nguyen TLP; Vecsernyés M; Fenyvesi F
    AAPS PharmSciTech; 2018 Oct; 19(7):3165-3176. PubMed ID: 30136176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significance of lipid matrix aging on in vitro release and in vivo bioavailability.
    Choy YW; Khan N; Yuen KH
    Int J Pharm; 2005 Aug; 299(1-2):55-64. PubMed ID: 15955645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of disintegrants in hard-gelatin capsules.
    Botzolakis JE; Augsburger LL
    J Pharm Pharmacol; 1984 Feb; 36(2):77-84. PubMed ID: 6143810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of the kinetics of degradation of 13-cis-retinoic acid and all-trans-retinoic acid in solution.
    Tan X; Meltzer N; Lindenbaum S
    J Pharm Biomed Anal; 1993 Sep; 11(9):817-22. PubMed ID: 8218526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stability of midazolam hydrochloride in extemporaneously prepared flavored gelatin.
    Bhatt-Mehta V; Johnson CE; Kostoff L; Rosen DA
    Am J Hosp Pharm; 1993 Mar; 50(3):472-5. PubMed ID: 8442465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determination of temazepam and related compounds in capsules by high-performance liquid chromatography.
    Fatmi AA; Hickson EA
    J Pharm Sci; 1988 Jan; 77(1):87-9. PubMed ID: 2894452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thermostability testing and degradation profiles of doxycycline in bulk, tablets, and capsules by HPLC.
    Injac R; Djordjevic-Milic V; Srdjenovic B
    J Chromatogr Sci; 2007 Oct; 45(9):623-8. PubMed ID: 17988452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of correlation between gelatin crosslinking indicators and influence factors].
    Liu JP; Ma X; Zhu JB
    Yao Xue Xue Bao; 2005 Mar; 40(3):279-84. PubMed ID: 15952604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of buffer and antioxidant on stability of a mercaptopurine suspension.
    Aliabadi HM; Romanick M; Desai S; Lavasanifar A
    Am J Health Syst Pharm; 2008 Mar; 65(5):441-7. PubMed ID: 18281736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of drug and diluent particle size on the in vitro release of drug from hard gelatin capsules.
    Newton JM; Bader F
    J Pharm Pharmacol; 1980 Mar; 32(3):167-71. PubMed ID: 6103930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The shell dissolution of various empty hard capsules.
    Chiwele I; Jones BE; Podczeck F
    Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):951-6. PubMed ID: 10923822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stability of oral liquid preparations of methylergometrine.
    Marigny K; Lohezic-Ledevehat F; Aubin F; Burgot G
    Pharmazie; 2006 Aug; 61(8):701-5. PubMed ID: 16964714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity.
    Ofner CM; Zhang YE; Jobeck VC; Bowman BJ
    J Pharm Sci; 2001 Jan; 90(1):79-88. PubMed ID: 11064381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stability of melatonin in an extemporaneously compounded sublingual solution and hard gelatin capsule.
    Haywood A; Burrell A; Breda Kv; George R; Testa C; Norris R
    Int J Pharm Compd; 2009; 13(2):170-4. PubMed ID: 23970011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.